UK Pharmaceutical Payments to Patient Organizations, 2012-2016

63 UK-based drug companies' yearly payment disclosures and 200 UK-based charities' financial accounts from 2012 to 2016. The dataset comprises aggregated information published as web supplements for a research paper on underreporting. It was compiled by Piotr Ozierański at the University of Bath.

Use Cases

• Analyze payment disclosure trends based on yearly reports from 63 drug companies.
• Compare financial flows between pharmaceutical firms and patient organizations based on aggregated charity accounts.
• Investigate transparency and underreporting in industry-patient group relationships based on the comparative study framework.

Strengths

• Data aggregates reports from 63 drug companies and 200 charities over a 5-year period (2012-2016).
• Data is structured as web supplements directly linked to a published academic paper for context.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Yearly disclosure reports from drug companies and financial accounts from charity regulator websites.

Collection Method

Aggregated from public disclosures and published accounts.

Time Range

2012-2016

Geography

United Kingdom